CICLOSIDOMINE HYDROCHLORIDE

Details

Stereochemistry	ACHIRAL
Molecular Formula	C13H21N4O3.Cl
Molecular Weight	316.784
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of CICLOSIDOMINE HYDROCHLORIDE

Structure Search

SMILES

[Cl-].O=C(NC1=C[N+](=NO1)N2CCOCC2)C3CCCCC3

InChI

InChIKey=KWILRBFYPCZOID-UHFFFAOYSA-N

InChI=1S/C13H20N4O3.ClH/c18-13(11-4-2-1-3-5-11)14-12-10-17(15-20-12)16-6-8-19-9-7-16;/h10-11H,1-9H2;1H

HIDE SMILES / InChI

Molecular Formula	C13H21N4O3
Molecular Weight	281.3308
Charge	1
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	ClH
Molecular Weight	36.461
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3656101 | https://www.ncbi.nlm.nih.gov/pubmed/3921036 | https://www.sciencedirect.com/science/article/pii/S1093326302001845?via%3Dihub

Ciclosidomine is morpholine derivative and nitric oxide donors developed for vascular diseases treatment.

Approval Year

PubMed

Title	Date	PubMed
Solution stability of ciclosidomine.	1987-05	3656101

Patents

Sample Use Guides

In Vivo Use Guide

1 mg/kg

Route of Administration: Oral

Substance Class	Chemical Created by `admin` on `Mon Mar 31 17:57:46 GMT 2025` Edited by `admin` on `Mon Mar 31 17:57:46 GMT 2025`
Record UNII	644XF6791D
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

NEOPRES

Preferred Name

English

CICLOSIDOMINE HYDROCHLORIDE

Common Name

English

CICLOSIDOMINE HYDROCHLORIDE [MART.]

Common Name

English

CICLOSIDOMINE HYDROCHLORIDE [MI]

Common Name

English

PR-G 138-CL

Code

English

1,2,3-OXADIAZOLIUM, 5-((CYCLOHEXYLCARBONYL)AMINO)-3-(4-MORPHOLINYL)-, CHLORIDE (1:1)

Systematic Name

English

PR-G-138-CL

Code

English

Code System Code Type Description

FDA UNII

644XF6791D